|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A phase Ⅱ randomized double-masked trial of pegaptanib,an anti-vascular endothelial growth factor aptamer,for diabetic macular edema显示文摘 | Cunningham ET Jr Adamis AP Altaweel M | 2005 | Ophthalmology2005，112，： | 1 |
| 2 | Interleulin 1 receptors in the brain and endorcrine tissues 显示文摘 | Cunningham ET Jr De Souza EB | 1993 | Immunology Today1993，14，： | 1 |
| 3 | Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals 显示文摘 | Adamis AP Altaweel M Bressler NM Cunningham ET Jr Davis MD Goldbaum M | 2006 | Ophthalmology2006，113，1： | 1 |
| 4 | Pegaptanib for neovascular age-related macular degeneration显示文摘 | Gragoudas ES Adamis AP Cunningham ET Jr | 2004 | N Engl J Med2004，351，： | 1 |
| 5 | A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer , for diabetic macular edema 显示文摘 | Cunningham ET Jr Adamis AP Altaweel M Aiello LP Bressler NM D' Amico DJ | 2005 | Ophthalmology2005，112，10： | 1 |
| 6 | Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials 显示文摘 | D' Amico DJ Masonson HN Patel M Adamis AP Cunningham ET Jr Guyer DR VEGF Inhibition Study in Ocular Neovascularization (VISION)Clhfical Trial Group | 2006 | Ophthalmology2006，113，6： | 1 |
| 7 | Ocular neovascularization in patients with uveitis 显示文摘 | Kuo IC Cunningham ET Jr | 2000 | Intern Ophthalmol Clin2000，40，： | 1 |
| 8 | A phase Ⅱrandomized double-masked trial of pegaptanib,an anti-vascular endothelial growth factor aptamer,for diabetic macular edema显示文摘 | Cunningham ET Jr Adamis AP Altaweel M | 2005 | Ophthalmology2005，112，： | 1 |
| 9 | Pegaptanib for neovascular age-related macular de- generation 显示文摘 | GRAGOUDAS ES ADAMIS AP CUNNINGHAM ET Jr FEIN- SOD M | 2004 | N Engl J Med2004，351，27： | 1 |
| 10 | Ocular toxoplasmosis 显示文摘 | Hovakimyan A Cunningham ET Jr | 2002 | Ophthalmol Clin North Am2002，15，3： | 1 |
| 11 | Practical approach to the use of corticosteroids in patients w ith uveitis显示文摘 | Cunningham ET Jr Wender JD | 2010 | Can J Ophthalmol2010，45，4： | 1 |
| 12 | A phase Ⅱ randomized double-masked trial of pegaptanib,an anti-vascular endothelial growth factor aptamer,for diabetic macular edema显示文摘 | Cunningham ET Jr Adamis AP Altaweel M Aiello LP Bressler NM D'Amico DJ | 2005 | Ophthalmology2005，112，10： | 1 |
| 13 | Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals显示文摘 | Adamis AP Altaweel M Bressler NM Cunningham ET Jr Davis MD Goldbaum M | 2006 | Ophthalmoloay2006，113，1： | 1 |
| 14 | Atypical presentations of ocular toxoplasmosis 显示文摘 | Smith JR Cunningham ET Jr | 2002 | Curr Opin Ophthalmol2002，13，6： | 1 |
| 15 | A phase II randomized double-masked trial of pegaptanib, an anti-vasc~ar endothelial growth factor aptamer,for diabetic macular edema显示文摘 | Cunningham ET Jr Adamis AP Atlaweel M Aiello LP Bressler NM D' Amico DJ | 2005 | Ophthalmology2005，112，10： | 1 |
| 16 | Pegatanib for neovascular age-related macular degeneration显示文摘 | Gragoudas ES Adamis AP Cunningham ET Jr | | 0，，27： | 1 |
| 17 | Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoidchorioretinopathy 显示文摘 | Pichi F Ciardella AP Cunningham ET Jr | 2014 | Retina2014，34，2： | 1 |
| 18 | Localization of tumor necrosis factor messenger RNA in normal and herpes simplex virus infected mouse eyes显示文摘 | Cunningham ET Jr Stalder A Sanna PP Liu SS Bloom FE Howes EL Jr | 1997 | Invest Ophthalmol Vis Sci1997，38，： | 1 |
| 19 | Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis显示文摘 | Stewart JM Cubillan LD Cunningham ET Jr | 2005 | Retina2005，25，8： | 1 |
| 20 | Pegaptanib for neovascular age-related macular degeneration显示文摘 | Gragoudas ES Adamis AP Cunningham ET Jr et a1 | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员